Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) Event Oct. 14, 2022, 20:33 UTC 30 1 comments (99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Announces Business Combination Comment Full text
RedHill Biopharma (RDHL) Event Oct. 14, 2022, 20:30 UTC 27 1 comments (19% Negative) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K) Comment Full text
Tcr2 Therapeutics Inc (the company was acquired by Adaptimmune Therapeutics plc (NASDAQ: ADAP)) (TCRR) Event Oct. 14, 2022, 20:17 UTC 65 1 comments (99% Neutral) TCR2 THERAPEUTICS INC. (TCRR) Files Form 8-K Comment Full text
ATAI Life Sciences (ATAI) Event Oct. 14, 2022, 20:16 UTC 61 1 comments (99% Neutral) ATAI LIFE SCIENCES N.V. (ATAI) Files Form 8-K Comment Full text
BeiGene Ltd (BGNE) Event Oct. 14, 2022, 20:09 UTC 60 1 comments (90% Positive) BEIGENE, LTD. (BGNE) Provides Update on superiority for publication Comment Full text
Curis Inc (CRIS) Event Oct. 14, 2022, 20:01 UTC 70 1 comments (99% Neutral) Curis, Inc. (CRIS) Announces New Board Appointment Comment Full text
Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX) Event Oct. 14, 2022, 12:48 UTC 66 1 comments (99% Neutral) FORMA THERAPEUTICS HOLDINGS, INC. (FMTX) Announces Executive Changes Comment Full text
Chinook Therapeutics Inc (KDNY) Event Oct. 14, 2022, 06:02 UTC 145 0 comments Chinook Therapeutics Announces Upcoming Presentations and Investor Conference Call at the American Society of Nephrology (ASN) Kidney Week 2022 Comment Full text
Aeglea BioTherapeutics Inc (AGLE) Event Oct. 14, 2022, 02:39 UTC 142 0 comments Aeglea BioTherapeutics Inc. - KOL Webinar on Classical Homocystinuria and Pegtarviliase Comment Full text
QuantumSi Inc (QSI) Event Oct. 13, 2022, 14:22 UTC 147 0 comments New Form 3 for Quantum-Si Incorporated Comment Full text